Plain-English translation of NCT07774312 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a new treatment called STN-targeted temporal interference stimulation (STN-tTIS) โ a non-invasive way to stimulate a specific part of the brain without surgery โ to see if it can reduce movement problems in people with Parkinson's disease. Researchers want to find out whether giving this stimulation once a week, twice a week, or five times a week makes a difference in how well it works and how long the benefits last. You would continue taking your regular Parkinson's medications while also receiving the stimulation.
While Parkinson's medications help many people, long-term use can cause side effects like movement problems that come and go unpredictably. This trial exists to explore whether this new non-invasive brain stimulation technique โ given at different schedules โ could offer a better option or work alongside current medicines to improve symptoms and quality of life.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would be randomly assigned to receive either the new brain stimulation treatment at one of three different schedules (once weekly, twice weekly, or five times weekly) or to continue your standard medication alone. The active treatment period lasts 2 weeks, followed by 2 weeks of follow-up visits where researchers check your motor symptoms, sleep, mood, thinking ability, and overall quality of life. You would also use a smartphone and smartwatch to track some of your movement at home during this time.
AI-generated summary from trial data ยท Aug 29, 2026 ยท Not medical advice
China